Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 18, 2026 | Moda Health | Sandostatin LAR (octreotide suspension) | Criteria changed |
| May 18, 2026 | Moda Health | Rytelo (imetelstat) | Criteria changed |
| May 18, 2026 | Moda Health | Rystiggo (rozanolixizumab-noli) | Criteria changed |
| May 18, 2026 | Moda Health | Ryoncil (remestemcel-L-rknd) | Criteria changed |
| May 18, 2026 | Moda Health | Rylaze (asparaginase Erwinia chrysanthemi (recombinant)-rywn) | Criteria changed |
| May 18, 2026 | Moda Health | Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) | Criteria changed |
| May 18, 2026 | Moda Health | Ryzneuta (efbemalenograstim alfa-vuxw) | Criteria changed |
| May 18, 2026 | Moda Health | Ruconest (C1 Esterase Inhibitor [recombinant]) | Criteria changed |
| May 18, 2026 | Moda Health | Roctavian (valoctocogene roxaparvovec-rvox) | Criteria changed |
| May 18, 2026 | Moda Health | Rivfloza (nedosiran) | Criteria changed |
| May 18, 2026 | Moda Health | Rituximab: Rituxan, Truxima, Ruxience, Riabni | Criteria changed |
| May 18, 2026 | Moda Health | Rituxan Hycela (rituximab and hyaluronidase human) | Criteria changed |
| May 18, 2026 | Moda Health | Revcovi (elapegademase-lvlr) | Criteria changed |
| May 18, 2026 | Moda Health | Recombinant antihemophilic factor (Obizur) | Criteria changed |
| May 18, 2026 | Moda Health | Reblozyl (luspatercept-aamt) | Criteria changed |
| May 18, 2026 | Moda Health | Ranibizumab: Byooviz Cimerli Lucentis Nufymco | Criteria changed |
| May 18, 2026 | Moda Health | Radicava (edaravone) | Criteria changed |
| May 18, 2026 | Moda Health | Qfitlia (fitusiran) | Criteria changed |
| May 18, 2026 | Moda Health | Provenge (sipuleucel-T) | Criteria changed |
| May 18, 2026 | Moda Health | Proleukin (aldesleukin, IL-2) | Criteria changed |
| May 18, 2026 | Moda Health | Poteligeo (mogamulizumab-kpkc) | Criteria changed |
| May 18, 2026 | Moda Health | Portrazza (necitumumab) | Criteria changed |
| May 18, 2026 | Moda Health | Pombiliti (cipaglucosidase alfa-atga) | Criteria changed |
| May 18, 2026 | Moda Health | Polivy (polatuzumab vedotin-piiq) | Criteria changed |
| May 18, 2026 | Moda Health | Piasky (crovalimab-akkz) | Criteria changed |
| May 18, 2026 | Moda Health | Phesgo (pertuzumab, trastuzumab and hyaluronidase-zzxf) | Criteria changed |
| May 18, 2026 | Moda Health | Perjeta (pertuzumab) | Criteria changed |
| May 18, 2026 | Moda Health | Penpulimab-KCQX (penpulimab-kcqx) | Criteria changed |
| May 18, 2026 | Moda Health | Pemetrexed: Alimta; Pemfexy; Pemrydi RTU; Axtle; Pemetrexed Ψ | Criteria changed |
| May 18, 2026 | Moda Health | Pedmark (sodium thiosulfate) | Criteria changed |
| May 18, 2026 | Moda Health | Aloxi (palonosetron) | Criteria changed |
| May 18, 2026 | Moda Health | Papzimeos (zopapogene imadenovec-drba) | Criteria changed |
| May 18, 2026 | Moda Health | Palivizumab (Synagis) | Criteria changed |
| May 18, 2026 | Moda Health | Padcev (enfortumab vedotin-ejfv) | Criteria changed |
| May 18, 2026 | Moda Health | Paclitaxel Albumin-Bound: Abraxane; Paclitaxel Albumin-Bound | Criteria changed |
| May 18, 2026 | Moda Health | Oxlumo (lumasiran) | Criteria changed |
| May 18, 2026 | Moda Health | Orencia (abatacept) | Criteria changed |
| May 18, 2026 | Moda Health | Opdualag (nivolumab/relatlimab-rmbw) | Criteria changed |
| May 18, 2026 | Moda Health | Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) | Criteria changed |
| May 18, 2026 | Moda Health | Opdivo (nivolumab) | Criteria changed |
| May 18, 2026 | Moda Health | Onpattro (patisiran lipid complex) | Criteria changed |
| May 18, 2026 | Moda Health | Onivyde (irinotecan liposome injection) | Criteria changed |
| May 18, 2026 | Moda Health | Omvoh (mirikizumab-mrkz) | Criteria changed |
| May 18, 2026 | Moda Health | Omisirge (omidubicel-onlv) | Criteria changed |
| May 18, 2026 | Moda Health | Ocrevus Zunovo (ocrelizumab and hyaluronidase) | Criteria changed |
| May 18, 2026 | Moda Health | Ocrevus (ocrelizumab) | Criteria changed |
| May 18, 2026 | Moda Health | Nulibry (fosdenopterin) | Criteria changed |
| May 18, 2026 | Moda Health | Nucala (mepolizumab) | Criteria changed |
| May 18, 2026 | Moda Health | Nplate (romiplostim) | Criteria changed |
| May 18, 2026 | Moda Health | Niktimvo (axatilimab-csfr) | Criteria changed |